Balyasny Asset Management’s MetLife MET Stock Holding History

Balyasny Asset Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-95,800	Closed	-$7.84M	–	3100
2024 Q4	$7.84M	Buy	95,800 +19,300	+25%	+$1.61M	0.01%	1074
2024 Q3	$6.31M	Sell	76,500 -433,500	-85%	-$32.4M	0.01%	1165
2024 Q2	$35.8M	Hold	510,000	–	–	0.06%	394
2024 Q1	$37.8M	Sell	510,000 -800	-0.2%	-$55.8K	0.07%	404
2023 Q4	$33.8M	Hold	510,800	–	–	0.06%	394
2023 Q3	$32.1M	Buy	+510,800	New	+$31.8M	0.07%	403
2023 Q2	–	Sell	-50,900	Closed	-$2.95M	–	2589
2023 Q1	$2.95M	Sell	50,900 -700	-1%	-$47.2K	0.01%	1296
2022 Q4	$3.73M	Buy	51,600 +1,600	+3%	+$115K	0.01%	1154
2022 Q3	$3.04M	Hold	50,000	–	–	0.01%	1262
2022 Q2	$3.14M	Buy	+50,000	New	+$3.31M	0.01%	1153

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balyasny Asset Management's MET Position: Q1 2026 in Review

Balyasny Asset Management reduced its MetLife (MET) stake by 39% in Q1 2026, selling an estimated $764K and leaving 16,020 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Balyasny Asset Management first reported a position in MET in Q1 2014 and has held it in 34 quarters since. The position peaked at $164M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Balyasny Asset Management held 16,020 shares of MetLife worth $1.13M as of Q1 2026.
Balyasny Asset Management sold 10,199 MetLife shares in Q1 2026, an estimated $764K.
MetLife made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2028 holding.
Balyasny Asset Management first reported a position in MetLife in Q1 2014 and has held it in 34 quarters since.
Balyasny Asset Management's MetLife position peaked at $164M in Q3 2024.
1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.